Astellas Pharma Inc. (4503) — Japan Stock Chart & News | StockAdder

(4503)

Astellas Pharma Inc.

Live chart and latest 4503 stock news.

Market ETF → EWJ Japan

Chart powered byTradingView— professional charts for every trader.Try it free →

4503 News

Has Astellas Pharma (TSE:4503) Run Too Far After Its 61% One Year Share Price Jump?

Jan 15, 2026 simplywall.st

Why You Might Be Interested In Astellas Pharma Inc. (TSE:4503) For Its Upcoming Dividend

Mar 25, 2026 TipRanks

Astellas Highlights R&D Strategy While Flagging Market and Development Risks

Mar 30, 2026 Investing.com

Astellas Pharma Q3 FY2025 slides: revenue up 10%, core profit surges 49%

Feb 4, 2026 TradingView — Track All Markets

4503 Stock Price and Chart — TSE:4503

Jul 28, 2025 GuruFocus

Q3 2026 Astellas Pharma Inc Earnings Presentation Transcript

Feb 4, 2026 Yahoo Finance

Reassessing Astellas Pharma (TSE:4503) Valuation After Positive PADCEV-Keytruda Phase 3 Bladder Cancer Results

Dec 21, 2025 simplywall.st

Astellas Pharma Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Feb 8, 2026 Yahoo Finance

Is It Too Late To Consider Astellas Pharma (TSE:4503) After An 83% One-Year Rally?

Feb 11, 2026 simplywall.st

Astellas Pharma (TSE:4503) Has Announced A Dividend Of ¥39.00

Feb 5, 2026 TipRanks

Astellas and HOVON Phase 3 AML Trial for Xospata Misses Survival Goal

Mar 9, 2026 Yahoo Finance

Astellas Pharma (TSE:4503): Evaluating Valuation Potential with Shares in a Stable Trading Range

Oct 7, 2025 simplywall.st

A Look At Astellas Pharma (TSE:4503) Valuation After Positive PADCEV Plus Keytruda Phase 3 Data

Mar 8, 2026 TipRanks

Astellas Settles Myrbetriq Patent Disputes with Lupin and Zydus

Feb 11, 2026 simplywall.st

How Investors Are Reacting To Astellas Pharma (TSE:4503) XOSPATA Frontline AML Trial Missing Survival Goal